Better detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP

摘要

BackgroundPatients with metabolic syndrome (MS) often have increased platelet aggregation. In order to determine which concentration detects a higher level of platelet aggregation in patients with MS, the agonists ADP and epinephrine were compared.